RIL
DAWN

Rothschild Investment LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

Rothschild Investment LLC’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.05K Buy
282
+55
+24% +$775 ﹤0.01% 1956
2025
Q4 		$2.12K Buy
227
+2
+0.9% +$17 ﹤0.01% 2333
2025
Q3 		$1.59K Buy
225
+105
+88% +$722 ﹤0.01% 2377
2025
Q2 		$780 Buy
120
+25
+26% +$172 ﹤0.01% 2583
2025
Q1 		$753 Buy
95
+45
+90% +$485 ﹤0.01% 2486
2024
Q4 		$634 Sell
50
-15
-23% -$209 ﹤0.01% 2446
2024
Q3 		$905 Buy
65
+35
+117% +$499 ﹤0.01% 2238
2024
Q2 		$413 Buy
30
+20
+200% +$293 ﹤0.01% 2134
2024
Q1 		$165 Buy
+10
New +$150 ﹤0.01% 1843

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Rothschild Investment LLC's DAWN Position: Q1 2026 in Review

Rothschild Investment LLC increased its Day One Biopharmaceuticals (DAWN) stake by 24% in Q1 2026, buying an estimated $775 and bringing the position to 282 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Rothschild Investment LLC first reported a position in DAWN in Q1 2024 and has held it in 9 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Rothschild Investment LLC held 282 shares of Day One Biopharmaceuticals worth $6.05K as of Q1 2026.
  • Rothschild Investment LLC bought 55 Day One Biopharmaceuticals shares in Q1 2026, an estimated $775.
  • Day One Biopharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #1956 holding.
  • Rothschild Investment LLC first reported a position in Day One Biopharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.